Irinotecan in Treating Patients With Metastatic or Recurrent Colorectal Cancer
NCT00002933
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
21
Enrollment
OTHER
Sponsor class
Conditions
Colorectal Cancer
Interventions
DRUG:
irinotecan hydrochloride
Sponsor
Case Comprehensive Cancer Center